Inventor profile of:

Guy Vergnault

City:

Kembs

Country:

France

Published Applications:

16

Last publication date:

2017-11-09

Top Assignees for applications by Guy Vergnault

The entities that hold a legal rights for patent applications filed by inventor Vergnault Guy:

Recent patent applications by Vergnault Guy

Guy Vergnault from Kembs, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-11-09
US20170319698A1
Human necessities

GASTRORETENTIVE GEL FORMULATIONS

#2 | 2016-09-15
US20160263045A1
Human necessities

Floating gastric retentive dosage form

#3 | 2016-09-08
US20160256396A1
Human necessities

Delayed release tablet with defined core geometry

#4 | 2016-01-14
US20160008288A1
Human necessities

Controlled release compositions

#5 | 2014-11-06
US20140328912A1
Human necessities

Delayed release tablet with defined core geometry

#6 | 2013-05-16
US20130122061A1
Human necessities

Delayed release tablet with defined core geometry

#7 | 2012-08-23
US20120213910A1
Human necessities

Tablets with Site- and Time- Controlled Gastrointestinal Release of Active Ingredient

#8 | 2012-08-02
US20120196938A1
Human necessities

Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia

#9 | 2012-07-12
US20120177739A1
Human necessities

Delayed release tablet with defined core geometry

#10 | 2012-07-12
US20120177734A1
Human necessities

Delayed release tablet with defined core geometry

#11 | 2011-07-21
US20110177167A1
Human necessities

Hydrophilic/lipophilic polymeric matrix dosage formulation

#12 | 2011-01-20
US20110014352A1
Performing operations; transporting

Method and apparatus for producing a centred compression coated tablet

#13 | 2010-11-18
US20100291209A1
Human necessities

ORGANIC COMPOUNDS

#14 | 2010-08-05
US20100196475A1
Human necessities

CONTROLLED RELEASE TABLET FORMULATION CONTAINING MAGNESIUM ALUMINOMETASILICATE

#15 | 2010-01-07
US20100003320A1
Human necessities

Hydrophilic/lipophilic polymeric matrix dosage formulation

#16 | 2008-09-11
US20080221174A1
Human necessities

CONTROLLED RELEASE NISOLDIPINE COMPOSITIONS

InventorID:

246759 ⎘